CIK: 1475714 - Address: C/o Protagonist Therapeutics, Inc., 7707 Gateway Blvd., Suite 140, Newark, CA 94560-1160
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1113-111325417025
S%wins7738465482241

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/13/18 20:32
11/5/18
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOExec CBM.d4164.5609124465D
12/23/16 17:11
12/23/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.d1665.5423307434D932029-8-6-120-30-2-15-30
12/23/16 17:11
12/23/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.d-1,51550.5023-30-6434D932029-8-6-120-30-2-15-30
5/13/16 18:10
5/6/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.d1001.23298124422D194891137-4-20-12-82451334
4/22/16 17:52
4/20/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.dm4138.49324917341D2101036936581894-7-4-13-6-5
4/22/16 17:52
4/20/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.dm-2,33948.0532-49-13341D2101036936581894-7-4-13-6-5
4/18/16 17:28
4/15/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.d128.493110341D23310717639352324-36-12-54
4/18/16 17:28
4/15/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.d-6748.0031-10341D23310717639352324-36-12-54
4/15/16 14:29
4/14/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.d238.493131341D233121191424127116-23-14-63
4/15/16 14:29
4/14/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.d-13148.0031-3-1341D233121191424127116-23-14-63
4/7/16 11:59
4/5/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.dm4488.49275318341D1821281752140412110-42-9-515-28
4/7/16 11:59
4/5/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.dm-2,27543.0927-53-13341D1821281752140412110-42-9-515-28
3/31/16 18:42
3/29/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBM.dm1606.8922237341D12068153-4222014721318-234-10
3/31/16 18:42
3/29/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEO,CBS.dm-93140.0222-23-6341D12068153-4222014721318-234-10
3/3/16 19:18
3/2/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOM.d1606.8915237340D1644791-55248123-122323527
3/3/16 19:18
3/2/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS.d-83836.0115-23-6340D1644791-55248123-122323527
2/8/16 17:00
2/4/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOM.d3254.56167126340D1561937-10-25-6-10-100114357454
2/8/16 17:00
2/4/16
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS.d-2,37633.3516-71-17340D1561937-10-25-6-10-100114357454
10/19/15 16:41
10/15/15
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS-1,97127.2422-72-20295D13515533266410110195-4-11274854
9/23/15 17:14
9/21/15
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS-5822.067-3-1367D4369-14-2358-6-100-215312782170
6/24/15 17:18
6/22/15
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS-1,85024.6710-75-20295D78-2122112155-120-197960
11/4/14 17:35
10/31/14
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS.m-42613.081-33-8357D25-856780412589562165
10/30/14 17:35
10/28/14
FPRXFive Prime Therapeutics IncDEHealthDrugPharmaceutical PreparationsWilliams Lewis TCADOP,CEOS.m-22813.131-17-4389D-4-6891181-33559956142

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact